Less Ads, More Data, More Tools Register for FREE

Pin to quick picksMicrosaic Regulatory News (MSYS)

  • There is currently no data for MSYS

Board Change

22 Oct 2021 07:00

RNS Number : 8818P
Microsaic Systems plc
22 October 2021
 

22 October 2021

 

Microsaic Systems plc

("Microsaic" or the "Company")

Board Change

 

Microsaic (AIM: MSYS), announces that, after 6 years of service, Bevan Metcalf, will be retiring as Finance Director on 17 December 2021. To ensure a smooth transition, the Company has appointed an Interim Head of Finance (non-board level), until a permanent successor is appointed.

 

Gerry Brandon, Chairman commented:

"Bevan has been a valued colleague since 2015. He has played a valuable role in supporting the management team through his vast knowledge and experience working within industry and more recently in the development and recent turnaround of the Company. I would like to thank him for the tremendous contribution that he has made to Microsaic since his appointment as Finance Director more than 6 years ago. On behalf of our shareholders, advisors and everyone at Microsaic I would like to wish him a happy and healthy retirement."

 

 

Enquiries:

Microsaic Systems plc

Glenn Tracey, CEO - Bevan Metcalf, FD

 

+44 (0)1483 751 577

Singer Capital Markets (Nominated Adviser & Joint Broker)

+44 (0)20 7496 3000

Aubrey Powell / Tom Salvesen / George Tzimas 

 

Turner Pope Investments (TPI) Limited (Broker)

Andy Thacker / James Pope

+44 (0) 20 3657 0050

About Microsaic

Microsaic listed on AIM in 2011 to develop and commercialise micro-engineering chip-based mass spectrometry equipment. Microsaic has a robust patent portfolio in cutting-edge technology purpose built for "Industry 4.0" which enables analytical detection and characterisation at the point-of-need, whether within a human health environment, conventional laboratory setting, or within a bioprocessing facility for continuous mass spectrometer detection and monitoring of data at any step in the process workflow.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
BOAEANEFALDFFFA
Date   Source Headline
8th Jun 201210:53 amRNSHolding(s) in Company
7th Jun 20127:00 amRNSHolding(s) in Company
30th May 20123:40 pmRNSHolding(s) in Company
30th May 201211:36 amRNSAGM Results
29th May 201210:35 amRNSHolding(s) in Company
29th May 20127:00 amRNSPlacing
11th May 20129:18 amRNSHolding(s) in Company
9th May 20127:00 amRNSRe Agreement
30th Apr 20122:22 pmRNSDistribution of Annual Report and Accounts
25th Apr 20127:00 amRNSPreliminary Results
18th Apr 201210:07 amRNSMicrosaic Exhibits at Analytica 2012
22nd Feb 201211:21 amRNSHolding(s) in Company
12th Dec 20117:00 amRNSDirectorate Change
25th Nov 20119:04 amRNSExercise of Share Options
2nd Nov 20118:59 amRNSHolding(s) in Company
5th Oct 20119:33 amRNSHolding(s) in Company
3rd Oct 201111:35 amRNSHolding(s) in Company
26th Sep 20117:00 amRNSInterim Results
8th Aug 201112:00 pmRNSManagement appointment
25th Jul 20115:18 pmRNSExercise of Share Options
22nd Jun 201111:38 amRNSResult of AGM
21st Jun 20113:16 pmRNSDistribution of Annual Report and Accounts
25th May 20114:10 pmRNSDirectorate Change
4th May 20115:39 pmRNSDirector/PDMR Shareholding
28th Apr 20114:22 pmRNSHolding(s) in Company
18th Apr 20114:01 pmRNSHolding(s) in Company
15th Apr 20113:40 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.